IL105061A - Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof - Google Patents

Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Info

Publication number
IL105061A
IL105061A IL10506193A IL10506193A IL105061A IL 105061 A IL105061 A IL 105061A IL 10506193 A IL10506193 A IL 10506193A IL 10506193 A IL10506193 A IL 10506193A IL 105061 A IL105061 A IL 105061A
Authority
IL
Israel
Prior art keywords
fragments
treatment
pharmaceutical compositions
neurodegenerative diseases
vip analogues
Prior art date
Application number
IL10506193A
Other languages
English (en)
Other versions
IL105061A0 (en
Inventor
Illana Gozes
Matityahu Fridkin
Original Assignee
Yeda Res & Dev
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Univ Ramot filed Critical Yeda Res & Dev
Priority to IL10506193A priority Critical patent/IL105061A/xx
Publication of IL105061A0 publication Critical patent/IL105061A0/xx
Priority to EP94103479A priority patent/EP0620008B1/en
Priority to DE69418931T priority patent/DE69418931T2/de
Priority to TW083101988A priority patent/TW290458B/zh
Priority to KR1019940005069A priority patent/KR100305453B1/ko
Priority to CNB941048179A priority patent/CN1140294C/zh
Priority to JP6084194A priority patent/JPH0769919A/ja
Priority to US08/413,708 priority patent/US5972883A/en
Publication of IL105061A publication Critical patent/IL105061A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL10506193A 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof IL105061A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
EP94103479A EP0620008B1 (en) 1993-03-16 1994-03-08 Use of vip, analogues and fragments thereof for the treatment of neurodegenerative diseases
DE69418931T DE69418931T2 (de) 1993-03-16 1994-03-08 Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
TW083101988A TW290458B (en:Method) 1993-03-16 1994-03-08
KR1019940005069A KR100305453B1 (ko) 1993-03-16 1994-03-15 Vip,또는그의유사체,유도체또는단편으로이루어지는제약조성물
CNB941048179A CN1140294C (zh) 1993-03-16 1994-03-15 血管活性肠肽其类似物及片段用于治疗神经变性疾病
JP6084194A JPH0769919A (ja) 1993-03-16 1994-03-16 Ｖｉｐ，その類縁体またはそのフラグメントを含む医薬組成物
US08/413,708 US5972883A (en) 1993-03-16 1995-03-30 Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Publications (2)

Publication Number Publication Date
IL105061A0 IL105061A0 (en) 1993-07-08
IL105061A true IL105061A (en) 2000-11-21

Family

ID=11064619

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Country Status (7)

Country Link
EP (1) EP0620008B1 (en:Method)
JP (1) JPH0769919A (en:Method)
KR (1) KR100305453B1 (en:Method)
CN (1) CN1140294C (en:Method)
DE (1) DE69418931T2 (en:Method)
IL (1) IL105061A (en:Method)
TW (1) TW290458B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
US6713445B1 (en) * 1998-04-06 2004-03-30 Advanced Immuni T, Inc. Peptides for treatment of HIV infection
US20020115605A1 (en) * 2000-08-24 2002-08-22 Matthew During Novel peptide with effects on cerebral health
CN1487952A (zh) 2000-11-28 2004-04-07 �ɶ����＼��ʵ���� 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物
HK1080363B (zh) * 2002-06-10 2007-12-21 Mondobiotech Ag 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
WO2008054498A2 (en) * 2006-04-07 2008-05-08 The Board Of Trustees Of The University Of Illinois Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders
KR101242066B1 (ko) 2010-05-19 2013-03-12 강원대학교산학협력단 Ｖｉｐ를 유효성분으로 함유하는 기분장애 예방 및 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9166291A (en) * 1990-12-21 1992-07-22 Case Western Reserve University Neuronal cholinergic differentiation factor
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0620008B1 (en) 1999-06-09
CN1140294C (zh) 2004-03-03
EP0620008A1 (en) 1994-10-19
DE69418931D1 (de) 1999-07-15
IL105061A0 (en) 1993-07-08
TW290458B (en:Method) 1996-11-11
CN1100327A (zh) 1995-03-22
KR100305453B1 (ko) 2001-11-22
DE69418931T2 (de) 2000-03-16
KR940021074A (ko) 1994-10-17
JPH0769919A (ja) 1995-03-14

Similar Documents

Publication Publication Date Title
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
HUT76676A (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
HU9402709D0 (en) Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis
IL105061A (en) Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
HUP0003244A3 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
EP0362162A3 (en) Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids and aids-related syndromes
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
EP0796105A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES COMPRISING THE B OLIGOMER OF PERTUSSIS TOXIN OR ITS SUB-UNITS
GB9304745D0 (en) Use of pharmaceutical formulations
GB9602444D0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
IL109414A0 (en) Pharmaceutical compositions containing sabeluzole for the treatment of chronic neurodegenerative diseases
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees